DataMEDS AI, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MEDS research report →
Price Chart
About the company
DataMEDS AI is a Health IT company focused on the vertical integration of technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units. The company incorporates its artificial intelligence platform EinsteinRx™ and blockchain-enabled smart contacts platform PharmacyChain™ to optimize the prescription medicines reimbursement and dispensing journey.
- CEO
- Prashant Patel
- IPO
- 2025
- Employees
- 31
- HQ
- Tampa, FL, US
Get TickerSpark's AI analysis on MEDS
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $3.80M
- P/E
- -0.03
- PEG
- 0.00
- P/S
- 0.47
- P/B
- -0.19
- EV/EBITDA
- -0.60
- Div Yield
- 0.00%
- Gross Margin
- -129.55%
- Op Margin
- -719.27%
- Net Margin
- -1100.30%
- ROE
- 877.58%
- ROIC
- -439.90%
Latest fiscal year · YoY change
- Revenue
- $23.34M+28.7%
- Gross Profit
- $-9,637,483-645.3%
- Op Income
- $-81,194,831
- Net Income
- $-101,274,530-1377.1%
- EPS
- $-71.50-1000.0%
- OCF Growth
- -786.1%
- FCF Growth
- -577.5%
- 52W High
- $97.50
- 52W Low
- $1.25
- 50D MA
- $2.85
- 200D MA
- $12.00
- Beta
- -1.52
- RSI (14)
- 32
- Avg Volume
- 269.63K
No earnings-call transcripts are available for MEDS yet.
- Free Float
- —
- Shares Outstanding
- 2.62M
- Float Shares
- 1.05M
of shares held by institutions
11 13F filers
Held by 17 ETFs
Biggest fund positions in MEDS by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 22, 26 | AJJARAPU SURENDRA K | other | 100,000 |
| Jun 22, 26 | AJJARAPU SURENDRA K | other | 100,000 |
| Jun 22, 26 | Patel Prashant | other | 100,000 |
| Jun 22, 26 | Patel Prashant | other | 100,000 |
| Mar 31, 26 | Patel Prashant | other | 5,000,000 |
| Mar 31, 26 | AJJARAPU SURENDRA K | other | 5,000,000 |
| Mar 31, 26 | Patel Prashant | other | 5,000,000 |
| Mar 31, 26 | Patel Prashant | other | 5,000,000 |
| Mar 31, 26 | AJJARAPU SURENDRA K | other | 5,000,000 |
| Mar 31, 26 | AJJARAPU SURENDRA K | other | 5,000,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our MEDS coverage
Recent articles, reports, and earnings notes.
No research on MEDS yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MEDS report →DataMeds AI Reports Second Quarter 2026 Financials and Provides Business Update
accessnewswire.com · Aug 17
DataMEDS AI Announces Its Board of Directors Approved September 9, 2026 as the Payment Date of the Previously Announced Distribution of Dream Bowl Meme Coin I Tokens to Record Holders of Common Stock and other Eligible Equity Securities as of the Record Date of August 7, 2026
accessnewswire.com · Aug 14
DataMeds AI Provides Update on Corexa Health's Pharmacy Division
accessnewswire.com · Aug 12
DataMeds AI Renames Pharmacy Subsidiaries Corexa Pharmacy and Corexa Tech & Hub Under New Corexa Health Division
accessnewswire.com · Aug 10
DataMeds AI Reiterates 50:1 Dream Bowl Meme Coin Token to Common Shares Dividend Ratio with an August 7, 2026 Record Date
accessnewswire.com · Aug 6
DataMeds AI to be Featured In-Person on Fox Business' Claman Countdown to Introduce "Health Lives Here"
accessnewswire.com · Aug 5
DataMeds AI's Corexa Pharmacy Launches Tollo Health's Tollovid(R) and Galactovid(TM)
accessnewswire.com · Jul 31
DataMeds AI Expands License with DataVault AI for Data Driven Outcome Healthcare-focused Blockchain and Data Monetization License
accessnewswire.com · Jul 29
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.